The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy
- PMID: 33679605
- PMCID: PMC7935543
- DOI: 10.3389/fendo.2020.621938
The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy
Abstract
Lipids can undergo modification as a result of interaction with reactive oxygen species (ROS). For example, lipid peroxidation results in the production of a wide variety of highly reactive aldehyde species which can drive a range of disease-relevant responses in cells and tissues. Such lipid aldehydes react with nucleophilic groups on macromolecules including phospholipids, nucleic acids, and proteins which, in turn, leads to the formation of reversible or irreversible adducts known as advanced lipoxidation end products (ALEs). In the setting of diabetes, lipid peroxidation and ALE formation has been implicated in the pathogenesis of macro- and microvascular complications. As the most common diabetic complication, retinopathy is one of the leading causes of vision loss and blindness worldwide. Herein, we discuss diabetic retinopathy (DR) as a disease entity and review the current knowledge and experimental data supporting a role for lipid peroxidation and ALE formation in the onset and development of this condition. Potential therapeutic approaches to prevent lipid peroxidation and lipoxidation reactions in the diabetic retina are also considered, including the use of antioxidants, lipid aldehyde scavenging agents and pharmacological and gene therapy approaches for boosting endogenous aldehyde detoxification systems. It is concluded that further research in this area could lead to new strategies to halt the progression of DR before irreversible retinal damage and sight-threatening complications occur.
Keywords: advanced lipoxidation end products; aldehydes; detoxification; diabetes; lipid peroxidation; oxidative stress; polyunsaturated fatty acids; retina.
Copyright © 2021 Augustine, Troendle, Barabas, McAleese, Friedel, Stitt and Curtis.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease.Future Med Chem. 2013 Feb;5(2):189-211. doi: 10.4155/fmc.12.202. Future Med Chem. 2013. PMID: 23360143 Review.
-
Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy.Curr Pharm Des. 2004;10(27):3349-60. doi: 10.2174/1381612043383124. Curr Pharm Des. 2004. PMID: 15544520 Review.
-
Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products.Diabetologia. 2011 Mar;54(3):690-8. doi: 10.1007/s00125-010-1971-x. Epub 2010 Nov 30. Diabetologia. 2011. PMID: 21116609
-
Lipoxidation in cardiovascular diseases.Redox Biol. 2019 May;23:101119. doi: 10.1016/j.redox.2019.101119. Epub 2019 Feb 25. Redox Biol. 2019. PMID: 30833142 Free PMC article. Review.
-
Advanced glycation end products and diabetic retinopathy.Curr Med Chem. 2013;20(26):3234-40. doi: 10.2174/09298673113209990025. Curr Med Chem. 2013. PMID: 23745547 Review.
Cited by
-
Renoprotective effect of a novel combination of 6-gingerol and metformin in high-fat diet/streptozotocin-induced diabetic nephropathy in rats via targeting miRNA-146a, miRNA-223, TLR4/TRAF6/NLRP3 inflammasome pathway and HIF-1α.Biol Res. 2024 Jul 20;57(1):47. doi: 10.1186/s40659-024-00527-9. Biol Res. 2024. PMID: 39033184 Free PMC article.
-
IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy.Dis Model Mech. 2023 Sep 1;16(9):dmm050174. doi: 10.1242/dmm.050174. Epub 2023 Sep 6. Dis Model Mech. 2023. PMID: 37671525 Free PMC article.
-
Development and validation of a diabetic retinopathy risk prediction model for middle-aged patients with type 2 diabetes mellitus.Front Endocrinol (Lausanne). 2023 Mar 15;14:1132036. doi: 10.3389/fendo.2023.1132036. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37008912 Free PMC article.
-
Targeting Scavenger Receptors in Inflammatory Disorders and Oxidative Stress.Antioxidants (Basel). 2022 May 9;11(5):936. doi: 10.3390/antiox11050936. Antioxidants (Basel). 2022. PMID: 35624800 Free PMC article. Review.
-
Distinct Mechanisms of Human Retinal Endothelial Barrier Modulation In Vitro by Mediators of Diabetes and Uveitis.Life (Basel). 2021 Dec 27;12(1):33. doi: 10.3390/life12010033. Life (Basel). 2021. PMID: 35054426 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials